Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type 1 diabetes: pathogenesis and prevention.

Kathleen M Gillespie1

  • 1Department of Clinical Science at North Bristol, University of Bristol, UK. k.m.gillespie@bristol.ac.uk

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|July 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diurnal Variation of Islet Autoantibody Titers in Established Type 1 Diabetes Suggests Restricted-Time Sampling Improves Aab Measurement and Detection.

Research square·2026
Same author

GADA testing: preparation for adult general population screening.

Diabetologia·2026
Same author

Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Relative maternal protection against type 1 diabetes: a combined analysis of five observational studies.

The Journal of clinical endocrinology and metabolism·2026
Same author

UK best practice recommendations for children and young people <18 years with pre-stage 3 type 1 diabetes, on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED).

Diabetic medicine : a journal of the British Diabetic Association·2025
Same author

Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.

Diabetes·2025
Same journal

Rheumatoid synovitis of the elbow mimicking rheumatoid nodule.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

What pool closures in Canada mean for health.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Fatal rabies in a child.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Otitis externa.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
See all related articles

Type 1 diabetes, an autoimmune disease, may be preventable by targeting immune responses or replacing beta cells. Early identification of at-risk individuals offers a window for intervention against this chronic disorder.

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Type 1 diabetes arises from autoimmune destruction of pancreatic beta cells, influenced by genetic and environmental factors.
  • The rising incidence and mortality from type 1 diabetes necessitate effective preventive strategies.
  • Identifying individuals at risk via islet cell autoantibody assays allows for potential intervention during the disease prodrome.

Purpose of the Study:

  • To explore the potential for preventing type 1 diabetes.
  • To identify emerging therapeutic targets for type 1 diabetes prevention.
  • To review current and future strategies for halting or reversing the autoimmune process in type 1 diabetes.

Main Methods:

  • Review of genetic data and preliminary clinical trial results.

Related Experiment Videos

  • Analysis of islet cell autoantibody assays for risk identification.
  • Exploration of immune tolerance induction and beta-cell regeneration strategies.

    • Main Results:

    • Genetic and preliminary data suggest T cells as a viable target for prevention.
    • Inducing tolerance to beta-cell autoantigens like insulin is a potential strategy.
    • Beta-cell replacement is a future possibility contingent on advancements in progenitor cell differentiation and replication.

    Conclusions:

    • Type 1 diabetes prevention is increasingly feasible through targeted immunotherapies.
    • Early detection and intervention during the prodromal phase are crucial.
    • Further research into beta-cell regeneration holds promise for future therapeutic approaches.